194 related articles for article (PubMed ID: 25891013)
1. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
[TBL] [Abstract][Full Text] [Related]
2. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome.
Kudo H; Tsuboi H; Asashima H; Takahashi H; Ono Y; Abe S; Honda F; Kondo Y; Wakasa Y; Takaiwa F; Takano M; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711
[No Abstract] [Full Text] [Related]
3. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
Sumida T; Iizuka M; Asashima H; Tsuboi H; Matsumoto I
Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
[TBL] [Abstract][Full Text] [Related]
4. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
[TBL] [Abstract][Full Text] [Related]
6. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
7. Role of immune response to M3 muscarinic acethylcholine receptor in the pathogenesis of Sjögren's syndrome.
Iizuka M; Wakamatsu E; Matsumoto I; Tsuboi H; Nakamura Y; Matsui M; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):87-91. PubMed ID: 20453444
[TBL] [Abstract][Full Text] [Related]
8. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
[TBL] [Abstract][Full Text] [Related]
9. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T
Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
[TBL] [Abstract][Full Text] [Related]
10. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.
Abe S; Tsuboi H; Kudo H; Asashima H; Ono Y; Honda F; Takahashi H; Yagishita M; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32614803
[TBL] [Abstract][Full Text] [Related]
11. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
Tsuboi H; Iizuka M; Asashima H; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):77-85. PubMed ID: 23629427
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].
Tsuboi H; Matsuo N; Iizuka M; Nakamura Y; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(4):222-8. PubMed ID: 20818151
[TBL] [Abstract][Full Text] [Related]
13. Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody.
Iizuka-Koga M; Ito M; Yumoto N; Mise-Omata S; Hayakawa T; Komai K; Chikuma S; Takahashi S; Matsumoto I; Sumida T; Yoshimura A
Clin Immunol; 2024 Jul; 264():110258. PubMed ID: 38762063
[TBL] [Abstract][Full Text] [Related]
14. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis.
Iizuka M; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2015 Jan; 25(1):158-60. PubMed ID: 24593169
[No Abstract] [Full Text] [Related]
15. Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor.
Yang L; Wang Y; Xing R; Bai L; Li C; Li Z; Liu X
Clin Immunol; 2016 Feb; 163():111-9. PubMed ID: 26794912
[TBL] [Abstract][Full Text] [Related]
16. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
17. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Asashima H; Matsumoto I
Mod Rheumatol; 2013 Sep; 23(5):841-5. PubMed ID: 23135882
[TBL] [Abstract][Full Text] [Related]
18. A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
Iizuka M; Tsuboi H; Matsuo N; Asashima H; Hirota T; Kondo Y; Iwakura Y; Takahashi S; Matsumoto I; Sumida T
J Immunol; 2015 Jan; 194(1):56-67. PubMed ID: 25411202
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against muscarinic acetylcholine receptor M
Yu X; Riemekasten G; Petersen F
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2053-2064. PubMed ID: 29772545
[TBL] [Abstract][Full Text] [Related]
20. RORγt antagonist improves Sjögren's syndrome-like sialadenitis through downregulation of CD25.
Ono Y; Tsuboi H; Moriyama M; Asashima H; Kudo H; Takahashi H; Honda F; Abe S; Kondo Y; Takahashi S; Matsumoto I; Nakamura S; Sumida T
Oral Dis; 2020 May; 26(4):766-777. PubMed ID: 31837283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]